Vitaflo International

Vitaflo International is a global leader in the development of specialized clinical nutritional products for patients with inherited metabolic disorders, renal disease, and conditions requiring a ketogenic diet. Founded in 1997 and headquartered in Liverpool, UK, the company focuses on creating palatable and convenient medical foods that improve patient compliance and quality of life. Their extensive product portfolio includes amino acid-based formulas, vitamin and mineral supplements, and modular nutrients tailored to specific metabolic pathways. In 2010, Vitaflo was acquired by Nestlé Health Science, significantly expanding its global reach and research capabilities. The company continues to innovate in the medical nutrition space, supporting healthcare professionals and patients across more than 40 countries. Their products are essential for the dietary management of rare conditions such as Phenylketonuria (PKU) and Maple Syrup Urine Disease (MSUD).